Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P04233 (HG2A_HUMAN) Homo sapiens (Human)

HLA class II histocompatibility antigen gamma chain UniProtKBInterProSTRINGInteractive Modelling

296 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5)

Available Structures

18 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L Heteromer
P07711;
210-274
NAG;
Assess
Crystal Structure of HLA-DR1 with CLIP102-120 Heteromer
P01903; P01911;
103-119
GOL;FMT;
Assess
HLA-DR1 with CLIP102-120(M107W) Heteromer
P01903; P01911;
104-118
Assess
MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange Heteromer
A0A4E9DJJ3; P01903;
103-117
EDO;
Assess
Crystal structure of murine class II MHC I-Ab in complex with a human CLIP peptide Heteromer
P14434; P14483;
103-117
NAG;
Assess
HLA-DR1 with covalently linked CLIP106-120 in reversed orientation Heteromer
P01903; P01911;
106-120
GOL;
Assess
HLA-DR1 with covalently linked CLIP106-120 in canonical orientation Heteromer
P01903; P01911;
106-120
GOL;
Assess
Crystal Structure of HLA-DR1 with CLIP106-120, flipped peptide orientation Heteromer
P01903; P01911;
106-120
Assess
Crystal Structure of HLA-DR1 with CLIP106-120, canonical peptide orientation Heteromer
P01903; P01911;
106-120
Assess
THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3 Heteromer
P01903; P01911;
103-117
NAG;
Assess
MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange Heteromer
A0A1V1IGJ9; P01903;
104-117
EDO;FLC;
Assess
F54C HLA-DR1 bound with CLIP peptide Heteromer
P01903; P01911;
103-116
Assess
HLA-DR1 bound with CLIP peptide Heteromer
P01903; P01911;
104-117
Assess
Crystal structure of HLA-DQ2.5-CLIP1 at 2.73 resolution Heteromer
P01909; Q5Y7D3;
103-116
Assess
MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange Heteromer
D7RIG5; P01903;
105-117
EDO;
Assess
Crystal structure of HLA-DQ2.5-CLIP2 Heteromer
P01909; Q5Y7D3;
109-120
Assess
HLA-DR ANTIGENS ASSOCIATED INVARIANT CHAINhomo-3-mer134-208
Assess
NMR structure of P41icf, a potent inhibitor of human cathepsin Lmonomer210-274
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7n4y.1.Amonomer0.56128-273
28.57
Assess
6o0d.2.Amonomer0.55190-265
40.79
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 47n4y.1.Amonomer0.56112-257
28.57
Assess
Isoform 48d6u.1.Amonomer0.56174-249
40.79
Assess